Form 4: Axogen Director Guido J. Neels Reports Acquisition of Shares and Stock Options

Director Guido J. Neels reports acquisition of common stock and stock options in Axogen, Inc. as part of an annual equity grant.

Summary

• On June 6, 2024, Guido J. Neels, a director of Axogen, Inc., reported the acquisition of 10,653 shares of common stock.
• These shares were acquired as restricted stock units.
• Neels also acquired 18,248 employee stock options with an exercise price of $7.04.
• These options are part of an annual equity grant for service as a Director.
• The options vest on June 6, 2025, and expire on June 6, 2034.
• Following these transactions, Neels beneficially owns 78,912 shares of Axogen, Inc. common stock and 18,248 stock options.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction (equity grant) and doesn't inherently indicate positive or negative sentiment. It's a neutral event.

Positives

• The acquisition of shares and stock options by a director signals confidence in the company's future.
• The equity grant incentivizes the director to contribute to the company's long-term success.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.

Comparison to Industry Standards

• Equity grants to directors are a common practice in publicly traded companies to align their interests with those of shareholders.
• The size and structure of the grant are typical for companies of Axogen's size and industry.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director compensation and ownership.
• The equity grant aligns the director's interests with those of the shareholders.

Key Dates